AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 29708818
Drug: 400 mg/day
RxNorm normalized name: ribociclib succinate 400 mg/day (200 mg x 2) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg/day of LI73014F2
Trial: 27043774
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (enalapril + aliskiren)
Trial: 24924842
Drug: Pulse ultrasound
RxNorm normalized name: dulse extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulse ultrasound treatment for popliteal cyamella three times weekly for 8 weeks
Trial: 24924842
Drug: Weekly shock
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly shock wave therapy for popliteal cyamella for the first 6 weeks
Trial: 24924842
Drug: Isokinetic muscular
RxNorm normalized name: Orchis mascula whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isokinetic muscular strengthening exercises three times weekly for 8 weeks
Trial: 12464461
Drug: Substance P
RxNorm normalized name: Substance P
DrugBank: Substance P (DB19198)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Substance P infusion
Trial: 12464461
Drug: NaCl infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: NaCl infusion (Control)
Trial: 10027502
Drug: Budesonide and
RxNorm normalized name: Budesonide and formoterol only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide and albuterol
Trial: 10027502
Drug: Nedocromil and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nedocromil and albuterol
Trial: 10027502
Drug: Placebo and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo and albuterol
Trial: 7560661
Drug: 12 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 micrograms formoterol solution
Trial: 7560661
Drug: 24 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24 micrograms formoterol solution
Trial: 7560661
Drug: 12 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 micrograms formoterol suspension
Trial: 7560661
Drug: 24 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24 micrograms formoterol suspension
Trial: 1981218
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no ACE inhibitors)
Trial: 7000628
Drug: Colloidal bismuth
RxNorm normalized name: Colloidal bismuth subcitrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colloidal bismuth subcitrate tablets
Trial: 31479770
Drug: Acuros dose-to-medium
RxNorm normalized name: Ricinus medius oil
DrugBank: Castor oil (DB11113)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acuros dose-to-medium (Dm,m)
Trial: 31479770
Drug: Acuros dose-to-water
RxNorm normalized name: HYALURONIC ACID 0.2 g in 100 g TOPICAL GEL [GZE Watery Sun Gel]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acuros dose-to-water (Dw,m)
Trial: 27921252
Drug: Oxycodone 10
RxNorm normalized name: oxycodone 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone 10 mg controlled-release tablets
Trial: 27921252
Drug: Oxycodone-Naloxone 10/5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone-Naloxone 10/5 mg controlled-release tablets
Trial: 27921252
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (Oxycodone)
Trial: 27921252
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (Oxycodone-Naloxone)
Trial: 24873806
Drug: Diluted vasopressin
RxNorm normalized name: Vasopressin
DrugBank: Vasopressin (DB00067)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diluted vasopressin injection
Trial: 22825784
Drug: Lipocryolysis treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipocryolysis treatment
Trial: 9403278
Drug: Felodipine ER,
RxNorm normalized name: Felodipine ER, 5 mg oral tablet, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine ER, 10 mg once daily
Trial: 9403278
Drug: Nifedipine SR,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine SR, 20 mg twice daily
Trial: 8427864
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human growth hormone (0.25‐0.5 units/kg per week s.c. given each evening) for 6 months
Trial: 3315286
Drug: Low-dose metoclopramide
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose metoclopramide and chlorpromazine
Trial: 3519233
Drug: High-dose metoclopramide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose metoclopramide
Trial: 31845733
Drug: Multicomponent exercise
RxNorm normalized name: meningococcus B, multicomponent vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multicomponent exercise intervention (MG)
Trial: 29510711
Drug: Primaquine anti-relapse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Primaquine anti-relapse treatment
Trial: 27347563
Drug: Rosuvastatin calcium,
RxNorm normalized name: Rosuvastatin Calcium, 5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin calcium, 20 mg/d
Trial: 22978103
Drug: Di'ao Xinxuekang
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Di'ao Xinxuekang Soft Capsule (DK)
Trial: 17560883
Drug: Control (placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (placebo or antiarrhythmic agents)
Trial: 15616068
Drug: Propofol (doses:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (doses: 0, 0.6, 0.8, 1.0, 1.2, 1.4, 1.6, 1.8, 2.0, 2.2, 2.4 mg/kg)
Trial: 15616068
Drug: Propofol (doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (doses > or = 1.0 mg/kg)
Trial: 15616068
Drug: Propofol (doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (doses not specified)
Trial: 7536681
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no CSF therapy)
Trial: 2201162
Drug: Topical terlipressin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical terlipressin gel
Trial: 7030227
Drug: 1% silver
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% silver sulphadiazine ointment
Trial: 28183565
Drug: Spinal anesthesia
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal anesthesia with phenylephrine infusion
Trial: 22472037
Drug: 42 g
RxNorm normalized name: PETROLATUM 42 g in 100 g TOPICAL OINTMENT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 42 g pistachios (RSG)
Trial: 22472037
Drug: 70 g
RxNorm normalized name: alcohol .70 g in 1 g TOPICAL GEL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 70 g pistachios (HSG)
Trial: 11391123
Drug: Remacemide (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remacemide (150 mg twice daily, increasing to 400 mg twice daily)
Trial: 9721393
Drug: Chlorhexidine gluconate
RxNorm normalized name: Chlorhexidine Gluconate
DrugBank: Chlorhexidine (DB00878)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chlorhexidine gluconate scrub solution
Trial: 3884410
Drug: Sulodexide (high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulodexide (high-dose glycosaminoglycan)
Trial: 25498055
Drug: Standard triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard triple therapy with CsA, everolimus twice daily and steroids (group A)
Trial: 25498055
Drug: Steroid-free immunosuppression
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid-free immunosuppression (group B)
Trial: 25498055
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy once daily (group C)
Trial: 22513495
Drug: 10-session behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-session behavioral treatment
Trial: 18511542
Drug: Minocycline treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minocycline treatment associated with lid hygiene
Trial: 10691818
Drug: L-arginine (2.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine (2.4 g/day)
Trial: 9432686
Drug: Induction chemotherapy
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction chemotherapy followed by concurrent chemoradiotherapy and definitive surgery
Trial: 9432686
Drug: Upfront surgery
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Upfront surgery followed by adjuvant radiation therapy
Trial: 9432686
Drug: Chemotherapy followed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chemotherapy followed by definitive concurrent chemoradiation up to 65 Gy radiation dose
Trial: 1302807
Drug: Single-dose oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose oral fluconazole (150 mg)
Trial: 1302807
Drug: Three-day local
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three-day local treatment with miconazole pessaries
Trial: 3895875
Drug: Lidocaine (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine (300 mg intramuscularly followed by 100 mg intravenously)
Trial: 27703240
Drug: BK-SE36 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BK-SE36 vaccine
Trial: 9493256
Drug: Repeated measures
RxNorm normalized name: eicosyl povidone (2 eicosyl branches-repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repeated measures of weight loss, drug plasma level, and pill count data
Trial: 7931890
Drug: High-dose, short-duration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose, short-duration ribavirin aerosol therapy (6 gm/100 ml water for 2 hours three times a day)
Trial: 7931890
Drug: Standard ribavirin
RxNorm normalized name: Ribavirin
DrugBank: Ribavirin (DB00811)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Standard ribavirin aerosol therapy (6 gm/300 ml water for 18 hours daily)
Trial: 26183686
Drug: Piragliatin 200
RxNorm normalized name: Dorzagliatin
DrugBank: Dorzagliatin (DB15123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piragliatin 200 mg BID
Trial: 23739279
Drug: solution (N-acetylcysteine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: solution (N-acetylcysteine and simethicone)
Trial: 23739279
Drug: water control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: water control (100 ml sterile water)
Trial: 20562781
Drug: Individualized dose
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Individualized dose regimen of amitriptyline (n=30)
Trial: 20562781
Drug: Empiric dose
RxNorm normalized name: aspirin / codeine phosphate Oral Tablet [Empirin with Codeine]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empiric dose regimen of amitriptyline (n=30)
Trial: 17356528
Drug: Sibutramine (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sibutramine (15 mg/day)
Trial: 10201469
Drug: Hydrocortisone (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrocortisone (100 mg by i.v. infusion immediately before endoscopy)
Trial: 10201469
Drug: Placebo (sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (sodium chloride administered in the same fashion)
Trial: 7773086
Drug: Bisoprolol, 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bisoprolol, 10 mg once a day
Trial: 7773086
Drug: Propranolol, 80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol, 80 mg twice a day
Trial: 7773086
Drug: Metoprolol, 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol, 100 mg twice a day
Trial: 2090533
Drug: Enalapril (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (10 mg once a day)
Trial: 376355
Drug: Danazol 200
RxNorm normalized name: danazol 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danazol 200 mg daily for 100 days
Trial: 29945169
Drug: P27A antigen
RxNorm normalized name: TRICOPHYTON ANTIGEN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: P27A antigen (10 or 50 μg) with Alhydrogel or GLA-SE (2.5 or 5 μg)
Trial: 29945169
Drug: Control rabies
RxNorm normalized name: rabies virus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control rabies vaccine (Verorab)
Trial: 28176150
Drug: Daily monetary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily monetary incentives
Trial: 28176150
Drug: Daily incentive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily incentive condition
Trial: 25882659
Drug: Active PEMF
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active PEMF therapy (60 minutes; frequency: 12 Hz; intensity: 12 Gauss)
Trial: 21855759
Drug: Subconjunctival injection
RxNorm normalized name: STREPTOMYCES GRISEUS 0.05 g in 1 mL SUBCONJUNCTIVAL INJECTION, SOLUTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subconjunctival injection of betamethasone acetate 5.7 mg/mL (Group 1)
Trial: 19074930
Drug: Effective CPAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Effective CPAP therapy
Trial: 17318417
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human erythropoietin (rHu‐EPO) at doses of 20, 40, 60, 90, 120, and 160 kIU
Trial: 15260961
Drug: Oral dextroamphetamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral dextroamphetamine (AMPH, 0.25 mg/kg)
Trial: 12108616
Drug: Intravenous porcine
RxNorm normalized name: Secretin porcine
DrugBank: Secretin porcine (DB09527)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous porcine secretin
Trial: 3094059
Drug: Methylphenidate (0.65
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate (0.65 mg/kg)
Trial: 30499799
Drug: Negative Pressure
RxNorm normalized name: DRESSING,NEGATIVE PRESSURE WOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Negative Pressure Wound Therapy (NPWT) among patients receiving a stoma
Trial: 28830411
Drug: Moringa oleifera
RxNorm normalized name: Moringa Oleifera
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moringa oleifera (M.O.) Lam. leaf powder supplementation (daily for 6 months)
Trial: 23632235
Drug: Conjugated linoleic
RxNorm normalized name: CONJUGATED LINOLEIC ACID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conjugated linoleic acid (CLA) supplementation, 3 g CLA/d for 6 weeks
Trial: 21590648
Drug: Pioglitazone (titrated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pioglitazone (titrated to 45 mg/day)
Trial: 21590648
Drug: Glibenclamide (titrated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glibenclamide (titrated to 15 mg/day)
Trial: 17053155
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil supplementation (1296 mg EPA + 864 mg DHA/day) for 8 weeks
Trial: 17053155
Drug: Flaxseed oil
RxNorm normalized name: Flaxseed Oil
DrugBank: Linseed oil (DB11357)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flaxseed oil supplementation (3510 mg alpha-linolenic acid + 900 mg linoleic acid/day) for 8 weeks
Trial: 9278195
Drug: Neoral (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoral (5 mg kg(‐1) dose)
Trial: 9278195
Drug: CsA capsules
RxNorm normalized name: CsA
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CsA capsules (5 mg kg(‐1) dose)
Trial: 1329172
Drug: Group sequential
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group sequential method for determining study duration in clinical trials
Trial: 1544695
Drug: Tamoxifen (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen (30 mg daily)
Trial: 3978249
Drug: Tamoxifen plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen plus nandrolone decanoate (100 mg i.m. once a week for four weeks, then every other week)
Trial: 21474675
Drug: High-dose methotrexate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose methotrexate (HDM) 5 g/m² as a 24-hour infusion at weeks 4, 7, 10, and 13
Trial: 21474675
Drug: High-dose methotrexate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose methotrexate (HDM)
Trial: 21474675
Drug: No high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No high-dose methotrexate (no HDM)
Trial: 16492230
Drug: Sumatriptan NS
RxNorm normalized name: NS-2359
DrugBank: NS-2359 (DB05805)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sumatriptan NS 5 mg
Trial: 15969863
Drug: Epoetin alfa
RxNorm normalized name: epoetin alfa
DrugBank: Erythropoietin (DB00016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epoetin alfa treatment
Trial: 14556671
Drug: Delayed epoetin
RxNorm normalized name: Epoetin
DrugBank: Erythropoietin (DB00016)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed epoetin alfa treatment
Trial: 9100722
Drug: Advance directives
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Advance directives with specific instructions to forgo life-sustaining treatment
Trial: 27904951
Drug: Peri-articular multimodal
RxNorm normalized name: casanthranol / docusate sodium Oral Capsule [Peri-Colace]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peri-articular multimodal drug injection (bupivacaine hydrochloride, morphine sulphate, epinephrine, and ketorolac)
Trial: 27904951
Drug: Peri-articular multimodal
RxNorm normalized name: casanthranol / docusate sodium Oral Capsule [Peri-Colace]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peri-articular multimodal drug injection
Trial: 24965797
Drug: Trauma-focused cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trauma-focused cognitive behavioral therapy (TF-CBT)
Trial: 21928867
Drug: Treatment entry
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment entry
Trial: 2895840
Drug: During treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: During treatment
Trial: 19330295
Drug: Concurrent radiochemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent radiochemotherapy (RTCT) with cisplatin 20 mg/m(2) x 5 days
Trial: 8914115
Drug: Placebo nicotine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo nicotine patch
Trial: 9579151
Drug: L-tyrosine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-tyrosine (100 mg/kg body weight/d)
Trial: 9579151
Drug: L-alanine (placebo)
RxNorm normalized name: L-alanine
DrugBank: Alanine (DB00160)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: L-alanine (placebo)
Trial: 7543651
Drug: IV infusion
RxNorm normalized name: IV INFUSION SET (WINTHROP)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV infusion of porcine galanin 500 micrograms in 100 mL saline
Trial: 7543651
Drug: IV injection
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV injection of GHRH (1-29)NH2 1 microgram/kg plus GnRH 100 micrograms at time 0 plus IV infusion of porcine galanin 500 micrograms in 100 mL saline from -10 to +30 minutes
Trial: 2615925
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg WEB 1881 FU
Trial: 2615925
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg WEB 1881 FU
Trial: 29783025
Drug: High-dose trivalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose trivalent inactivated influenza vaccine (HDTIV)
Trial: 20869984
Drug: Maintenance-tailored therapy
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance-tailored therapy (MTT)
Trial: 20869984
Drug: Standard behavior
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard behavior therapy (SBT)
Trial: 16929238
Drug: Chilli diet
RxNorm normalized name: Chilli pepper
DrugBank: Capsicum (DB10897)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chilli diet (30 g/day of a chilli blend with 55% cayenne chilli)
Trial: 9631311
Drug: Lansoprazole 30
RxNorm normalized name: lansoprazole 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole 30 mg daily and amoxicillin 500 mg three times a day for 14 days (LA)
Trial: 9631311
Drug: Lansoprazole 30
RxNorm normalized name: lansoprazole 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole 30 mg daily and amoxicillin 500 mg three times a day for 14 days plus miconazole gel 100 mg three times a day for 14 days (LAM)
Trial: 3244616
Drug: Heidelberg capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heidelberg capsule (HC) ingestion after a standardized 500-kcal breakfast in males
Trial: 3244616
Drug: Heidelberg capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heidelberg capsule (HC) ingestion in supine posture
Trial: 3244616
Drug: Heidelberg capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heidelberg capsule (HC) ingestion in elderly males (greater than 65 years)
Trial: 28969659
Drug: Azithromycin 20
RxNorm normalized name: azithromycin 20 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin 20 mg/kg/day (maximum 1000 mg/day) in a single daily dose
Trial: 28969659
Drug: Co-trimoxazole 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-trimoxazole 60 mg/kg/day (maximum 3000 mg/day) in two divided doses
Trial: 26585952
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 supplementation (1200 IU daily)